Cefuroxime USP with Clavulanic Acid USP
Composition : Fuclav-125 : Cefuroxime USP 125 mg + Clavulanic Acid USP 31.25 mg Tablet.
Fuclav-250 : Cefuroxime USP 250 mg + Clavulanic Acid USP 62.5 mg Tablet.
Fuclav-500 : Cefuroxime USP 500 mg + Clavulanic Acid USP 125 mg Tablet.
Indication : It is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below : Pharyngitis/tonsillitis, Acute bacterial otitis media, Acute bacterial maxillary sinusitis, Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis, Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, Uncomplicated gonorrhea, Early lyme disease.
Dosage and administration : Please see prescribing description for more information.
Packing :
Fuclav-125 : 2x7's tablets in blister pack.
Fuclav-250 : 2x7's tablets in blister pack.
Fuclav-500 : 2x7's tablets in blister pack.